標(biāo)題: Titlebook: Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy; Rajni A. Sethi,Igor J. Barani,Mack Roach, III Boo [打印本頁] 作者: 人工合成 時間: 2025-3-21 16:05
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy影響因子(影響力)
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy影響因子(影響力)學(xué)科排名
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy網(wǎng)絡(luò)公開度
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy被引頻次
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy被引頻次學(xué)科排名
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy年度引用
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy年度引用學(xué)科排名
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy讀者反饋
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy讀者反饋學(xué)科排名
作者: harrow 時間: 2025-3-21 22:53 作者: Lineage 時間: 2025-3-22 03:00
Radiobiology of Stereotactic Radiosurgery and Stereotactic Body Radiotherapyer shorter time periods. In this chapter we discuss those biological factors thought to impact clinical outcome, repair, reoxygenation, redistribution, repopulation, and radiosensitivity and compare and contrast their relevance in the era of hypofractionated treatment.作者: 間接 時間: 2025-3-22 05:13 作者: adipose-tissue 時間: 2025-3-22 12:41 作者: NICHE 時間: 2025-3-22 15:37
Gynecologic Sitesble to tolerate invasive brachytherapy procedures, develop pelvic recurrences, or present with oligometastatic disease. This chapter explores treatment indications, technique, and management of toxicity and reviews published literature regarding SBRT for gynecologic malignancies.作者: 感染 時間: 2025-3-22 17:21 作者: Eructation 時間: 2025-3-23 00:00 作者: 產(chǎn)生 時間: 2025-3-23 01:29
Einzelversuche mit Buchen-Nutzholz, oncology, along with the development of megavoltage treatment machines, imaging-based treatment planning, and intensity-modulated radiation therapy. This chapter outlines the historical foundations and development of these technologies.作者: flourish 時間: 2025-3-23 07:45
https://doi.org/10.1007/978-3-662-24753-2er shorter time periods. In this chapter we discuss those biological factors thought to impact clinical outcome, repair, reoxygenation, redistribution, repopulation, and radiosensitivity and compare and contrast their relevance in the era of hypofractionated treatment.作者: 護(hù)身符 時間: 2025-3-23 11:22
https://doi.org/10.1007/978-3-0348-5208-1end-to-end measurements and also by using third-party phantoms, such as that provided by IROC (Imaging and Radiation Oncology Corte), before using the system clinically. Routine quality assurance (QA) and quality control (QC) must be strictly maintained to ensure delivery accuracy and patient safety.作者: evasive 時間: 2025-3-23 16:44
Roland Guggisberg,Bruno Thürlimann bladder cancer and renal cell carcinoma. We review the literature supporting SBRT for each of these sites and discuss practical aspects of SBRT planning and delivery, including simulation and field design, dose prescriptions and dose constraints, and expected toxicity and management.作者: Commonplace 時間: 2025-3-23 18:15
Versuche zur Gewinnung von Kartoffeleiwei?ble to tolerate invasive brachytherapy procedures, develop pelvic recurrences, or present with oligometastatic disease. This chapter explores treatment indications, technique, and management of toxicity and reviews published literature regarding SBRT for gynecologic malignancies.作者: 颶風(fēng) 時間: 2025-3-24 00:48 作者: aesthetician 時間: 2025-3-24 05:58
ons regarding the appropriateness of SRS and SBRT and guide treatment and evaluation. .Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy. can be easily referenced in the clinic and is a valuable guide for oncology practitioners.?978-3-319-21897-7作者: Irksome 時間: 2025-3-24 08:28 作者: bronchiole 時間: 2025-3-24 14:43
Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy978-3-319-21897-7作者: Concomitant 時間: 2025-3-24 15:10 作者: 修飾 時間: 2025-3-24 20:16 作者: 高歌 時間: 2025-3-25 00:03 作者: Conclave 時間: 2025-3-25 05:01
https://doi.org/10.1007/978-3-0348-5208-1abilities. Therefore, clinical validation of treatment planning, linac delivery, and imaging systems must be validated rigorously, both by performing end-to-end measurements and also by using third-party phantoms, such as that provided by IROC (Imaging and Radiation Oncology Corte), before using the作者: 箴言 時間: 2025-3-25 07:51 作者: 執(zhí)拗 時間: 2025-3-25 11:45
https://doi.org/10.1007/978-3-663-04429-1, early data suggest that stereotactic outcomes are superior to conventionally fractionated strategies for both primary and metastatic tumors alike. Dose limiting toxicities and treatment precision are ongoing areas of controversy and investigation.作者: ILEUM 時間: 2025-3-25 19:05
https://doi.org/10.1007/978-3-7091-5323-9nd large institutional series, in both inoperable and otherwise operable patient populations. Current studies seek to further optimize treatment parameters to maximize tumor ablation and minimize toxicity as definitive therapy for early-stage disease and as adjuvant therapy in locally advanced lung 作者: climax 時間: 2025-3-25 20:49
Gerhard Leiber,Dieter Schauwinhold organs, dose limiting toxicity remains the primary impediment to treatment, but advances in targeting and tracking precision have improved outcomes over recent years. Greater advances may be achieved in the coming years through the combination of stereotactic body radiotherapy with systemic chemoth作者: GEST 時間: 2025-3-26 02:51 作者: 胖人手藝好 時間: 2025-3-26 07:17
Versuche zur Gewinnung von Kartoffeleiwei?ical malignancies treated with definitive radiation. Stereotactic body radiotherapy (SBRT) has been explored for the treatment of patients who are unable to tolerate invasive brachytherapy procedures, develop pelvic recurrences, or present with oligometastatic disease. This chapter explores treatmen作者: 棲息地 時間: 2025-3-26 08:28 作者: 膠狀 時間: 2025-3-26 12:45
Introduction to Stereotactic Radiosurgery and Stereotactic Body Radiotherapy,ign conditions. They have altered the way clinicians think about fractionation, and therefore they rank among the most important advances in radiation oncology, along with the development of megavoltage treatment machines, imaging-based treatment planning, and intensity-modulated radiation therapy. 作者: FLEET 時間: 2025-3-26 17:54
Radiobiology of Stereotactic Radiosurgery and Stereotactic Body Radiotherapylivered over a protracted period of time. The increasing adoption of image guided techniques has permitted the delivery of much larger single doses over shorter time periods. In this chapter we discuss those biological factors thought to impact clinical outcome, repair, reoxygenation, redistribution作者: justify 時間: 2025-3-27 00:26 作者: auxiliary 時間: 2025-3-27 02:04 作者: Mitigate 時間: 2025-3-27 08:30 作者: nurture 時間: 2025-3-27 11:25 作者: 大溝 時間: 2025-3-27 14:01 作者: coagulate 時間: 2025-3-27 17:52
Genitourinary Siteslent tumor control and acceptable toxicity. The use of SBRT has also been studied, although less extensively, for other genitourinary sites, including bladder cancer and renal cell carcinoma. We review the literature supporting SBRT for each of these sites and discuss practical aspects of SBRT plann作者: Tremor 時間: 2025-3-27 23:45 作者: nerve-sparing 時間: 2025-3-28 05:55 作者: 利用 時間: 2025-3-28 07:53
Rajni A. Sethi,Igor J. Barani,Mack Roach, IIIPresents evidence-based guidelines to help inform decisions regarding the appropriateness of stereotactic radiosurgery and stereotactic body radiotherapy and guide treatment technique.Details clinical作者: GROWL 時間: 2025-3-28 10:48
http://image.papertrans.cn/h/image/421296.jpg作者: 安定 時間: 2025-3-28 17:02 作者: AVERT 時間: 2025-3-28 22:13 作者: 配置 時間: 2025-3-28 23:56 作者: 種屬關(guān)系 時間: 2025-3-29 03:35
https://doi.org/10.1007/978-3-7091-5323-9nd large institutional series, in both inoperable and otherwise operable patient populations. Current studies seek to further optimize treatment parameters to maximize tumor ablation and minimize toxicity as definitive therapy for early-stage disease and as adjuvant therapy in locally advanced lung cancer.作者: Inferior 時間: 2025-3-29 10:06 作者: 典型 時間: 2025-3-29 12:17 作者: dendrites 時間: 2025-3-29 16:21
Spine, early data suggest that stereotactic outcomes are superior to conventionally fractionated strategies for both primary and metastatic tumors alike. Dose limiting toxicities and treatment precision are ongoing areas of controversy and investigation.作者: APO 時間: 2025-3-29 21:20
Lungnd large institutional series, in both inoperable and otherwise operable patient populations. Current studies seek to further optimize treatment parameters to maximize tumor ablation and minimize toxicity as definitive therapy for early-stage disease and as adjuvant therapy in locally advanced lung cancer.作者: 清唱劇 時間: 2025-3-30 01:38
Digestive System organs, dose limiting toxicity remains the primary impediment to treatment, but advances in targeting and tracking precision have improved outcomes over recent years. Greater advances may be achieved in the coming years through the combination of stereotactic body radiotherapy with systemic chemotherapy or targeted molecular agents.
